Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 123 Next »
Viewing Page 1 of 3 | Showing Results 1 - 5 of 14

AURORA: A Phase 3 Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH.Inclusion Criteria:Histological...

Kris Kowdley, M.D.
  • Swedish Medical Center

A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)

A randomized, double-blind study to assess the safety, tolerability, PK and efficacy of EDP-305 in subjects with primary biliary...

Kris Kowdley, M.D.
  • Swedish Medical Center

A Multi-Part, Randomized, Double-Blind, Placebo Controlled Study to Assess the Safety, Tolerability and Efficacy of LJN452 in Patients with Primary Biliary Cirrhosis

A multi-part study to assess safety, tolerability and efficacy of LJN452 in patients with primary biliary cirrhosis.Inclusion Criteria:•Diagnosis...

Kris Kowdley, M.D.
  • Swedish Medical Center

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Elafibranor at Doses of 80 mg and 120mg After 12 Weeks of Treatment in Patients With Primary Biliary Cholangitis and Inadequate Response to Ursodeoxycholic Acid

Inclusion Criteria:Definite or probable PBC diagnosis as demonstrated by the presence of at least 2 of the following 3 diagnostic factors:History...

Kris Kowdley, M.D.
  • Swedish Medical Center

Lesion Detection in Cirrhotic Patients With Contrast Enhanced Ultrasound and the Accuracy of Contrast Enhanced Ultrasound Li-RADS for Hepatocellular Carcinoma (HCC) Diagnosis

Lesion Detection in Cirrhotic Patients With Contrast Enhanced Ultrasound and the Accuracy of Contrast Enhanced Ultrasound Li-RADS for...

Lisa Finch, M.D.
  • Swedish Medical Center
« Previous 123 Next »
Viewing Page 1 of 3 | Showing Results 1 - 5 of 14